Journal ArticleOPEN ACCESS

Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States

  • Adeoye O
  • Hornung R
  • Khatri P
  • et al.
Stroke (2011) 42(7) 1952-1955
DOI: 10.1161/strokeaha.110.612358
N/ACitations
Citations of this article
25Readers
Mendeley users who have this article in their library.

Abstract

Background and Purpose—Recombinant tissue-type plasminogen activator (rtPA) is the only approved therapy for acute ischemic stroke (AIS). In 2004, 1.8% to 2.1% of AIS patients in the United States ...

Cite

CITATION STYLE

APA

Adeoye, O., Hornung, R., Khatri, P., & Kleindorfer, D. (2011). Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States. Stroke, 42(7), 1952–1955. https://doi.org/10.1161/strokeaha.110.612358

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free